| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/09/2006 | US20060030573 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
| 02/09/2006 | US20060030568 Crystal modificaion of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use |
| 02/09/2006 | US20060030565 Amide derivatives and nociceptin antagonists |
| 02/09/2006 | US20060030560 Pyrimidine compounds |
| 02/09/2006 | US20060030559 Diazole derivatives |
| 02/09/2006 | US20060030558 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds |
| 02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/09/2006 | US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 02/09/2006 | US20060026776 Method of dyeing keratin-containing fibres |
| 02/09/2006 | DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments |
| 02/09/2006 | DE19809994B4 Clathrate von Bis-[6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(phen-4-ylazo)-pyridin-2-on]ethylen Ethylene clathrates of bis [6-hydroxy-4-methyl-5- (3-methylimidazolium-1-yl) -3- (phen-4-ylazo) -pyridin-2-one] |
| 02/09/2006 | CA2578261A1 Pyrazole derivative |
| 02/09/2006 | CA2576112A1 Piperidine derivatives as histamine h3 receptor ligands |
| 02/09/2006 | CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 02/09/2006 | CA2575936A1 Quinoline derivatives as neurokinin receptor antagonists |
| 02/09/2006 | CA2574626A1 Antiplatelet agent and process for producing the same |
| 02/09/2006 | CA2574147A1 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 02/09/2006 | CA2573869A1 Generic probes for the detection of phosphorylated sequences |
| 02/09/2006 | CA2573223A1 Aromatic compound |
| 02/09/2006 | CA2573198A1 Nicotinamide derivatives and their use as therapeutic agents |
| 02/09/2006 | CA2573124A1 Anti-inflammatory medicaments |
| 02/09/2006 | CA2573063A1 Compounds useful for inhibiting chk1 |
| 02/09/2006 | CA2572740A1 Alkyl-and piperidine-substituted benzimidazole-derivates |
| 02/09/2006 | CA2571937A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 02/08/2006 | EP1622893A1 New alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants |
| 02/08/2006 | EP1622881A1 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having parp enzyme inhibitory effect |
| 02/08/2006 | EP1622879A1 Pyrimidine compounds and pests controlling composition containing the same |
| 02/08/2006 | EP1622876A1 Cannabinoid receptor ligands and uses thereof |
| 02/08/2006 | EP1622872A1 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 02/08/2006 | EP1622616A2 Inhibitors of akt activity |
| 02/08/2006 | EP1622615A2 Naphthyridine integrase inhibitors |
| 02/08/2006 | EP1622611A1 Imidazolin-2-ylaminophenyl amides as ip antagonists |
| 02/08/2006 | EP1622610A1 1-(2h-pyrazol-3-yl)-3- 4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl -urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations |
| 02/08/2006 | EP1622608A2 Compositions and methods for treating cancer |
| 02/08/2006 | EP1622569A2 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP1187815B1 4-phenyl-pyrimidine derivatives |
| 02/08/2006 | EP1183243B1 Short-acting benzodiazepines |
| 02/08/2006 | EP0911328B1 Substituted aminocycloalkylpyrrolidine derivatives |
| 02/08/2006 | CN1732165A 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732159A 2-oxopyrimidine derivatives and their use as human leukocyte elastase inhibitors |
| 02/08/2006 | CN1732158A Indazole derivatives as CRF antagonists |
| 02/08/2006 | CN1732154A Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 02/08/2006 | CN1732153A Novel piperidine derivatives as modulators of chemokine receptor CCR5 |
| 02/08/2006 | CN1732006A 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as P2X7-inhibitors for the treatment of inflammatory diseases |
| 02/08/2006 | CN1732002A Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 02/08/2006 | CN1731994A Prophylactic and therapeutic agent for neuropathy |
| 02/08/2006 | CN1240757C Highly nucleated thermoplastic articles |
| 02/08/2006 | CN1240688C Quinazoline compounds |
| 02/08/2006 | CN1240680C 1,4-pentadiene-3-ketone compound containing halogenoindyl, and method for preparing same and medicinal use thereof |
| 02/08/2006 | CN1240679C 2- and 2,5-substituted phenylketoenols |
| 02/07/2006 | US6995269 Guanidinobenzamides |
| 02/07/2006 | US6995265 Reacting nicotine with trimethylsilylchloride and lithium in polar aprotic solvent to form 3-(1-methylpyrrolidin-2-yl)-1,4-bis-trimethylsilanyl-1,4-dihydropyridine; chemical intermediates such as to nicotinic acetylcholine receptor modulators |
| 02/07/2006 | US6995264 Process for preparing aripiprazole |
| 02/07/2006 | US6995263 Indolyl and dihydroindolyl derivatives, their manufacture and use as pharmaceutical agents |
| 02/07/2006 | US6995261 Treatment of meningitis, septic shock, infections, reperfusion injuries, hepatitis, pancreatitis; bone, autoimmune, viral, and respiratory system disorders; antiinflammatory, antiarthritic, and antitumor agents |
| 02/07/2006 | US6995185 Δ1-pyrrolines used as pesticides |
| 02/07/2006 | US6995182 1-sulfonyl pyrrolidine derivatives |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/07/2006 | US6995179 N-type calcium channel blockers, antiischemic agents |
| 02/07/2006 | US6995178 Insecticidal anthranilamides |
| 02/07/2006 | US6995176 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/07/2006 | US6995175 Anticancer agents |
| 02/07/2006 | US6995174 for inhibiting proteases |
| 02/07/2006 | US6995172 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/07/2006 | US6995168 such as 5-[8-(3-dimethylcarbamoyl-3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-pentanoic acid; side effect reduction; for stimulating opioid receptors |
| 02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
| 02/07/2006 | US6995161 Central nervous system disorders |
| 02/07/2006 | US6995160 Sodium channel blockers |
| 02/07/2006 | US6995159 4-piperazin-1-yl-2-(pyridin-2-ylmethoxy)-pyrimidine, 2-(6-methyl-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine, and 2-(6-chloro-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine; for treatment of seizure and eating disorders; reduced side effects |
| 02/07/2006 | US6995156 Platelet adenosine diphosphate receptor antagonists |
| 02/07/2006 | US6995155 Imines such as 4-(3-((3-(2,4-dichlorophenyl)propanoyl)amino)-1-(3-(morpholin-4-yl)propyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-5-yl)benzamide, administered for prophylaxis of Alzheimer's disease |
| 02/07/2006 | US6995144 for example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 02/07/2006 | US6995006 Incubating a producer cell in a cell culture medium; wherein the producer cell is other than a KB cell, whereby greater than about 102 particles are produced from the producer cell |
| 02/07/2006 | CA2360308C Glucocorticoid receptor modulators |
| 02/07/2006 | CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 02/07/2006 | CA2216288C Uracilic hydroquinone derivatives as type iv allergy inhibitors |
| 02/02/2006 | WO2006012374A1 Substituted aryl-amine derivatives and methods of use |
| 02/02/2006 | WO2006012310A2 Carbazole derivatives for treating polycystic kidney disease |
| 02/02/2006 | WO2006012256A2 Fkbp binding composition and pharmaceutical use thereof |
| 02/02/2006 | WO2006012173A1 Amido compounds and their use as pharmaceuticals |
| 02/02/2006 | WO2006011050A2 Pyridine derivatives |
| 02/02/2006 | WO2006011040A1 Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 02/02/2006 | WO2006011035A1 Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them |
| 02/02/2006 | WO2006010969A1 New heterocyclic carboxylic acid amide derivatives |
| 02/02/2006 | WO2006010968A1 New aryloxy acetic acid amide derivatives |
| 02/02/2006 | WO2006010967A1 Kynurenic acid amide derivatives as nr2b receptor antagonists |
| 02/02/2006 | WO2006010966A1 New benzoyl urea derivatives |
| 02/02/2006 | WO2006010965A1 Indole-2 -carboxamidine derivatives as nmda receptor antagonists |
| 02/02/2006 | WO2006010964A1 New 4-benzylidene-piperidin derivatives |
| 02/02/2006 | WO2006010750A1 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 02/02/2006 | WO2006010643A1 Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/02/2006 | WO2006010591A2 Quinazoline derivatives |
| 02/02/2006 | WO2006010570A1 2-(pyridin-2-yl)-pyrimidines and their use for controlling pathogenic fungi |
| 02/02/2006 | WO2006010546A2 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
| 02/02/2006 | WO2006010446A2 Medicinal use of receptor ligands |
| 02/02/2006 | WO2005115392A3 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |